Risk of Alzheimer disease with the ε4 allele for apolipoprotein E in a population-based study of men aged 62-73 years

Alzheimer Disease and Associated Disorders

Volumn 12, Issue 1, 1998, Pages 40-44

  Breitner, John C S ^a,c   Jarvik, Gail P ^b   Plassman, Brenda L ^a   Saunders, Ann M ^a   Welsh, Kathleen A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Age; Alzheimer disease; Apolipoprotein E; Etiologic fraction; Population; Risk

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; GENE FREQUENCY; GENOTYPE; HETEROZYGOSITY; HUMAN; MALE; NORMAL HUMAN; ONSET AGE; POPULATION RESEARCH; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL ANALYSIS;

EID: 0032450315     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002093-199803000-00006     Document Type: Article

References (33)

1. Basun H, Grut M, Winblad B, Lannfelt L. Apolipoprotein ∈4 allele and disease progression in patients with late-onset Alzheimer's disease. Neurosci Lett 1995;183:32-4.
2. Breitner JCS. New epidemiologic strategies in Alzheimer's disease may provide clues to prevention and cause. Neurobiol Aging 1994;150:S175-7.
3. Breitner JCS, Welsh KA, Gau BA, et al. Alzheimer's disease in the National Academy of Sciences-National Research Council Registry of aging twin veterans. III. Detection of cases, longitudinal results, and observations on twin concordance. Arch Neurol 1995;52:763-71.
4. Breteler MMB, Claus JJ, van Duijn CM, Launer LJ, Hofman A. Epidemiology of Alzheimer's disease. Epidemiol Rev 1992;14:59-82.
5. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-3.
6. Corder EH, Saunders AM, Risch NJ, et al. Apolipoprotein E type 2 allele decreases the risk of late onset Alzheimer disease. Nature Genet 1994;7:180-4.
7. Corder EH, Basun H, Lannfelt L, Viitanen M, Winblad B. Apolipoprotein E-∈4 gene dose. Lancet 1995a;346:967.
8. Corder EH, Saunders AM, Strittmatter WJ, et al. Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease. Neurology 1995b;45:1323-8.
9. Corder EH, Lannfelt L, Viitanen M, et al. Apolipoprotein E genotype determines survival in the oldest old (85 years or older) who have good cognition. Arch Neurol 1996;53:418-22.
10. Fabsitz RR, Kalousdian S, Carmelli D, Robinette D, Christian JC. Characteristics of participants and nonparticipants in the NHLBI twin study. Acta Genet Med Gemellog 1988;37:217-28.
11. Feinleib M, Garrison RJ, Fabsitz R, et al. The NHLBI twin study of cardiovascular disease risk factors: methodology and summary of results. Am J Epidemiol 1977;106:284-5.
12. Henderson AS, Easteal S, Jorm AF, et al. Apolipoprotein E allele ∈4, dementia, and cognitive decline in a population sample. Lancet 1995;346:1387-90.
13. Hendrie HC, Hall KS, Hui S, et al. Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans. Ann Neurol 1995;37:118-20.
14. Hrubec Z, Neel JV. The National Academy of Sciences-National Research Council Twin Registry: ten years of operation. In: Nance WE, ed. Twin Research: Proceedings of the Second International Congress on Twin Studies, part B, vol. 24B. New York: Alan R. Liss, 1978:153-72.
15. Hyman BT, Gomez-Isla T, Briggs M, et al. Apolipoprotein E and cognitive change in an elderly population. Ann Neurol 1996;40:55-66.
16. Jarvik GP, Larson EB, Goddard K, Kukull WA, Schellenberg GD, Wijsman EM. Influence of apolipoprotein E genotype on the transmission of Alzheimer disease in a community-based sample. Am J Hum Genet 1996;58:191-200.
17. Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol 1985;42:1097-105.
18. Kuusisto J, Koivisto K, Kervinen K, et al. Association of apolipoprotein E phenotypes with late-onset Alzheimer's disease: population-based study. Br Med J 1994;309:636-8.
19. Levin ML. The occurrence of lung cancer in man. Acta Unio Int Contra Cancrum 1953;19:531-41.
20. Maestre G, Ottman R, Stern Y, et al. Apolipoprotein E and Alzheimer's disease: ethnic variation in genotypic risks. Ann Neurol 1995;37:254-9.
21. Mayeux R, Stern Y, Ottman R, et al. The apolipoprotein ∈4 allele in patients with Alzheimer's disease. Ann Neurol 1993;34:752-4.
22. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of the DHSS task force on Alzheimer's disease. Neurology 1984;34:939-44.
23. Mirra SS, Heyman A, McKeel D, et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part III. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-86.
24. Myers RH, Schaefer EJ, Wilson PWF, et al. Apolipoprotein E ∈4 association with dementia in a population-based study: the Framingham study. Neurology 1996;46:673-7.
25. Payami H, Zareparsi S, Montee KR, et al. Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women. Am J Hum Genet 1996;58:803-11.
26. Plassman BL, Breitner JCS. Apolipoprotein E and cognitive decline in Alzheimer's disease. Neurology 1996;47:317-20.
27. Reed T, Carmelli D, Christian JC, Selby JV, Fabsitz RR. The NHLBI male veteran twin study data. Genet Epidemiol 1993;10:513-7.
28. Roses AD. Apolipoprotein E alleles as risk factors in Alzheimer disease. Annu Rev Med 1996;47:387-400.
29. Roses AD, Strittmatter WJ, Pericak-Vance MA, Corder EH, Saunders AM, Schmechel DE. Clinical application of apolipoprotein E genotyping to Alzheimer's disease. Lancet 1994;343:1564-5.
30. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele ∈4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-72.
31. Selby JV, Reed T, Newman B, Fabsitz RR, Carmelii D. Effects of selective return on estimates of heritability for body mass index in the National Heart, Lung, and Blood Institute twin study. Genet Epidemiol 1991;8:371-80.
32. Sobel E, Louhija J, Sulkava R. Lack of association of apolipoprotein E allele ∈4 with late-onset Alzheimer's disease among Finnish centenarians. Neurology 1995;45:903-7.
33. van Duijn CM, de Knijff P, Cruts M, et al. Apolipoprotein ∈4 allele in a population-based study of early-onset Alzheimer's disease. Nature Genet 1994;7:74-8.